NHL News & Analysis

3 articles

Market Mood

1 Bullish2 Neutral0 Bearish
YES Network, MSG Networks to Transition Streaming to DAZN in 2026
TechNeutral7/29/2026

YES Network, MSG Networks to Transition Streaming to DAZN in 2026

YES Network and MSG Networks will migrate their streaming services to DAZN during the 2026-2027 NBA and NHL seasons. This move follows their exit from the Gotham Sports app after roughly two years. Fans will continue using the Gotham app through the end of the season. Pricing details for DAZN's subscription plans for New York-area teams have not yet been released. This transition is significant for fans accustomed to their original networks while reflecting broader challenges faced by regional sports networks in the evolving streaming landscape.

Read More: YES Network, MSG Networks to Transition Streaming to DAZN in 2026
NHL-Hurricanes (CAR) Win Second Stanley Cup Title in History
SportsNeutral6/15/2026

NHL-Hurricanes (CAR) Win Second Stanley Cup Title in History

The Carolina Hurricanes (CAR) secured their second Stanley Cup title with a victory over the Vegas Golden Knights. This win highlights the team's strong performance throughout the playoffs, ultimately leading to the selection of Jordan Staal as the Most Valuable Player. The significance of this victory may impact team valuations and merchandise sales. This historic achievement underlines the growing competitiveness of NHL teams.

Read More: NHL-Hurricanes (CAR) Win Second Stanley Cup Title in History
Legend Biotech (LEGN) Stock Price Target Raised by UBS on NHL Outlook
EarningsBullish6/3/2026

Legend Biotech (LEGN) Stock Price Target Raised by UBS on NHL Outlook

UBS increased its price target for Legend Biotech (LEGN) reflecting a positive outlook on its NHL therapy development. No specific new price target was provided in the report. The adjustment signifies UBS's confidence in the market potential of LEGN's therapeutic advancements and could influence investor sentiment positively. This change might impact trading volumes as investors react to the report, indicating potential shifts in the stock's market dynamics.

Read More: Legend Biotech (LEGN) Stock Price Target Raised by UBS on NHL Outlook